European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - hypercalcemia; breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases - bondronat is indicated for:prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases;treatment of tumour-induced hypercalcaemia with or without metastases.

European Union - English - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1). a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - naproxen, quantity: 500 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; magnesium stearate; iron oxide yellow; povidone - for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, for the symptomatic treatment of primary dysmenorrhoea, for the relief of acute and/or chronic pain states in which there is an inflammatory component and as an analgesic in acute migraine attack.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - naproxen, quantity: 250 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; iron oxide yellow; povidone; magnesium stearate - for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, for the symptomatic treatment of primary dysmenorrhoea, for the relief of acute and/or chronic pain states in which there is an inflammatory component and as an analgesic in acute migraine attack.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000 - elovax one dose is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults aged 18 years and over.

Canada - English - Health Canada

atnahs pharma uk limited - tetracosactide (tetracosactide zinc hydroxide) - suspension - 1mg - tetracosactide (tetracosactide zinc hydroxide) 1mg - adrenocortical insufficiency

Canada - English - Health Canada

syntex inc. - ketorolac tromethamine - tablet - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

syntex inc. - ketorolac tromethamine - liquid - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

atnahs pharma uk limited - olsalazine sodium - capsule - 250mg - olsalazine sodium 250mg - anti-inflammatory agents

Canada - English - Health Canada

atnahs pharma uk limited - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides